老年卵巢癌化疗患者外周血T淋巴细胞亚群及生活质量的动态变化
CSTR:
作者:
作者单位:

(1.张家口市第一医院东院妇科,河北 张家口 075000;2.张家口市第一医院西院妇科,河北 张家口 075000;3.河北北方学院附属第一医院妇产科,河北 张家口 075000)

作者简介:

通讯作者:

中图分类号:

基金项目:

河北省医学科学研究课题计划(20221897)


Dynamic change of T lymphocyte subsets in peripheral blood and quality of life in elderly patients with ovarian cancer during chemotherapy
Author:
Affiliation:

(1.Department of Gynaecology of East Campus,Zhangjiakou 075000, Hebei Province, China;2.Department of Gynaecology of West Campus, Zhangjiakou First Hospital, Zhangjiakou 075000, Hebei Province, China;3.Department of Gynaecology and Obstetrics, First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China)

Fund Project:

This work was supported by Hebei Medical Science Research Project (20221897).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 观察老年卵巢癌患者化疗期间外周血T淋巴细胞亚群及生活质量的动态变化。方法 将2018年3月至2023年6月张家口市第一医院收治的150例拟行化疗的老年卵巢癌患者作为研究对象,分别在化疗前(T0)、化疗初期(T1)、化疗中期(T2)、化疗末期(T3)、化疗结束后1个月(T4)及结束后3个月时(T5)对其生活质量[卵巢癌治疗功能评价系统(FACT-O)]及外周血T淋巴细胞亚群(CD3、CD4、CD8、CD4/CD8)进行观察。采用Pearson相关性分析评估患者各时期免疫状态与其生活质量间的相关性。采用SPSS 22.0软件进行数据分析。根据数据类型,组间比较分别采用t检验及χ2检验。结果 剔除中途退出化疗者、不愿填写问卷者及随访者,共129例患者完成化疗及研究指标收集。与T0时相比,患者CD3、CD4、CD4/CD8水平明显降低,T2时开始回升,但T5时水平依旧低于T0时水平(P<0.05);与T0时相比,患者CD8水平明显上升,T2时开始下降,至T5时,CD8水平依旧高于T0时水平(P<0.05)。老年卵巢癌化疗患者FACT-O量表中生理状况得分在T0、T1、T2、T3时呈依次下降趋势,T4、T5时间段内逐渐回升,但依旧低于T0时水平(P<0.05);情感状况及功能状况得分在T1时最低,后逐渐回升,在T3时均恢复至T0时水平,且维持至T5时(P<0.05);卵巢癌特异性模块及量表总得分在T0、T1、T2、T3时呈依次下降趋势,在T4时逐渐回升,但T5时水平依旧低于T0时水平(P<0.05)。Pearson相关性分析提示,老年卵巢癌化疗患者T1时CD4/CD8水平与其同时间段内的生理状况(r=0.412)、功能状况(r=0.374)、卵巢癌特异性模块(r=0.386)以及总得分(r=0.345)间呈正相关(均P<0.001),T3时CD4/CD8水平与其同时间段内生活质量中生理状况(r=0.336)、卵巢癌特异性模块(r=0.325)以及总得分(r=0.394)间呈正相关(均P<0.001)。结论 老年卵巢癌患者化疗初期细胞免疫抑制状态最为严重,随着化疗疗程的进展,其免疫抑制状况逐渐减轻,老年卵巢癌患者化疗期间整体生活质量呈下降趋势,化疗后1个月逐渐开始回升;此外,患者化疗期间外周血CD4/CD8水平与其生活质量之间呈正相关性。

    Abstract:

    Objective To dynamically observe T lymphocyte subsets in the peripheral blood and quality of life in elderly patients with ovarian cancer during chemotherapy. Methods A total of 150 elderly patients with ovarian cancer scheduled to receive chemotherapy in the First Hospital of Zhangjiakou were enrolled in the study from March 2018 to June 2023. The quality of life [functional assessment of cancer therapy-ovary cancer (FACT-O)] and T lymphocyte subsets in the peripheral blood (CD3, CD4, CD8, CD4/CD8) were observed before chemotherapy (T0), at the beginning of chemotherapy (T1), in the middle of chemotherapy (T2) and at the end of chemotherapy (T3), at 1 month after the chemotherapy (T4), and at 3 months after chemotherapy (T5). Pearson correlation analysis was used to analyze the correlation between immune status and quality of life of patients at each period. SPSS 22.0 was used for statistical analysis. Data comparison between two groups was performed using t test orχ2 test depending on data type. Results Of all patients, 129 completed chemotherapy and research index collection after excluding those who withdrew from chemotherapy, unwilling to fill out the questionnaire and lost to follow-up. Statistics found that the levels of CD3, CD4 and CD4/CD8 were significantly reduced compared with those at T0, began to rise at T2, but the levels at T5were still lower than those at T0 (P<0.05). Compared with that at T0, the level of CD8 in patients was increased significantly and began to decrease at T2, and the CD8 level at T5 was still higher than that at T0 (P<0.05). FACT-O score for physiological status in elderly patients with ovarian cancer during chemotherapy showed a decreasing trend at T0, T1, T2 and T3, and gradually rose at T4 and T5, but were still lower than that at T0 (P<0.05). The scores of emotional status and functional status were the lowest at T1, then were gradually enhanced, returned to the T0 level at T3 and maintained at T5 (P<0.05). The ovarian cancer-specific module score and total score showed decreasing trends at T0, T1, T2 and T3, and gradually increased at T4, but the scores at T5 were still lower than those at T0 (P<0.05). Pearson correlation analysis showed that the CD4/CD8 level at T1 in elderly patients with ovarian cancer during chemotherapy was positively correlated with physiological status (r=0.412; P<0.001), functional status (r=0.374; P<0.001), ovarian cancer-specific module (r=0.386; P<0.001) and total score (r=0.345; P<0.001). The CD4/CD8 level at T3 was positively correlated with physiological status (r=0.336; P<0.001), ovarian cancer-specific module (r=0.325; P<0.001) and total score (r=0.394; P<0.001) of quality of life scale. Conclusion The cellular immunosuppression status in elderly patients with ovarian cancer is the most serious in the early stage of chemotherapy. With the progress of chemotherapy, the immunosuppression status is gradually relieved. The overall quality of life in elderly patients with ovarian cancer shows a downward trend during chemotherapy and gradually begins to rise at 1 month after chemotherapy. In addition, there is a positive correlation between peripheral blood CD4/CD8 and quality of life of patients during chemotherapy.

    参考文献
    相似文献
    引证文献
引用本文

景雅超,王丽,孙丽敏,吕霞明,石克威.老年卵巢癌化疗患者外周血T淋巴细胞亚群及生活质量的动态变化[J].中华老年多器官疾病杂志,2025,24(3):202-206
DOI:10.11915/j. issn.1671-5403.2025.03.041

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-01-09
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-27
  • 出版日期:
文章二维码